Cipla

Cipla is 2nd largest pharmaceutical company in India in terms of retail sales. Cipla manufactures an extensive range of pharmaceutical & personal care products and has presence in over 170 countries across the world. Cipla's product range includes Pharmaceuticals, Animal Health Care Products, OTC, Bulk Drugs, Flavours & Fragrances, and Agrochemicals. Cipla also provides a host of consulting services such as preparation of product and material specifications, evaluation of existing production facilities to meet GMP, definition of appropriate plant size and technologies etc.

The origins of Cipla can be traced back to 1935, when Dr Khwaja Abdul Hamied set up "The Chemical, Industrial and Pharmaceutical Laboratories Ltd", popularly known by the acronym Cipla, in a rented bungalow, at Bombay Central. Cipla was registered as a public limited company on August 17, 1935. Cipla's first product was launched into the market in 1937. In 1940, during the Second World War when the drug supplies were cut off, Cipla started producing fine chemicals. In 1944, Cipla bought the premises at Bombay Central to build a modern pharmaceutical laboratory. In 1946, Cipla's product for hypertension, Serpinoid, was exported to the American Roland Corporation. In 1952, Cipla set up first research division for attaining self-sufficiency in technological development. In 1960, Cipla started operations at second plant at Vikhroli, Mumbai. In 1968, Cipla manufactured ampicillin for the first time in India. In 1976, Cipla launched medicinal aerosols for asthma. In 1982, Cipla's fourth factory became operational at Patalganga, Maharashtra. In 1984, Cipla developed anti-cancer drugs, vinblastine and vincristine in collaboration with the National Chemical Laboratory, Pune. In 1991, Cipla pioneered the manufacture of the antiretroviral drug, zidovudine. In 1994, Cipla's fifth factory began commercial production at Kurkumbh, Maharashtra. In 1997, Cipla launched transparent Rotahaler, the world's first such dry powder inhaler device. In 2000, Cipla became the first company, outside the USA and Europe to launch CFC-free inhalers. In 2002, Cipla set up four state-of-the-art manufacturing facilities set up in Goa. In 2003, Cipla launched TIOVA (Tiotropium bromide), a novel inhaled, long-acting anticholinergic bronchodilator. In 2005, Cipla set up a state-of-the-art facility for manufacture of formulations at Baddi, Himachal Pradesh.

Cipla's products include:

Pharmaceuticals: Cipla manufactures anabolic steroids, analgesics/antipyretics, antacids, anthelmintics, anti-arthritis, anti-inflammatory drugs, anti-TB drugs, antiallergic drugs, anticancer drugs, antifungal, antimalarials, antispasmodics, antiulcerants, immunosuppressants etc,

Animal Health Care Products: These include: aqua products, equine products, poultry products, products for companion animals, and products for livestock animals.

OTC: These include: child care products, eye care products, food supplements, health drinks, life style products, nutraceuticals & tonics, skin care products, and oral hygiene products.

Flavour & Fragrance: Cipla manufactures a wide range of flavours, which are used in foods and beverages, fruit juices, baked goods, and oral hygiene products. Cipla fragrances have wide ranging applications such as in personal care products, laundry detergents and room fresheners.

Major Achievements of Cipla:

Note: The above information was last updated on 21-07-2007